Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | Patent Publication Number 20130231314

US 20130231314 A1
Patent NumberUS 08530498 B1
Application Number13858708
Filled DateApr 8, 2013
Priority DateMay 17, 2002
Publication DateSep 5, 2013
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsJerome B. Zeldis
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.